Podcasts about Roche

Send us a textThe mountains beckon, and Anna Gibson answers with a fresh approach to trail running excellence. Coming off an impressive 11th place finish at the prestigious Zagama mountain marathon in Spain, Gibson shares what it's like to race through corridors of 100,000 screaming fans while tackling 9,000 feet of elevation gain.What makes Gibson's success particularly fascinating is her training philosophy. Unlike many elite trail runners, she thrives on remarkably low mileage—typically just 40-45 weekly running miles—supplemented with strategic cycling sessions. "If I can go for two or three-hour bike rides in a week, that's six hours of training that I could not run," she explains, revealing how this cross-training approach allows her to build tremendous aerobic capacity without breaking down her body. Even when preparing for her marathon-distance race at Zagama, she topped out at just 60 miles in her highest week ever.Working with renowned coach David Roche has helped Gibson develop this personalized approach. Their relationship embodies mutual trust, with Roche pushing her at precisely the right moments while giving her freedom to adapt the training as needed. Gibson candidly discusses her upcoming race at Sunapee, which serves as the US selection race for the Mountain Running World Championships. At 26, despite international success, she has yet to represent the United States at Worlds—something she hopes to change by qualifying for both the Vertical Kilometer and Mountain Classic teams.As trail running continues to professionalize, Gibson offers a glimpse into this evolution through her experience with Brooks, describing their comprehensive team approach where athletes travel together and receive extensive support at international races. She also touches on her future plans, including maintaining her track career alongside her trail endeavors, showcasing the versatility that makes her one of the sport's most exciting talents.Tune in to hear how this rising star balances multiple disciplines, navigates international racing, and approaches the challenges of competing at the highest level in mountain running.Follow James on IG - @jameslaurielloFollow the Steep Stuff Podcast on IG - @steepstuff_podUse code steepstuffpod for 25% off your cart at UltimateDirection.com! 

On this week's Full Time Review, The Athletic's Art de Roche and Laia Cervello join the podcast to discuss how Arsenal stunned Barcelona to win the 2024-25 UEFA Women's Champions League. Was it the biggest upset in a final the competition has ever seen? How did Arsenal honor their rich history while creating a new legacy? Who were the key players and top performers? And, what was behind Barcelona's collapse in Lisbon?PLUS: Host Jillian Sakovits has the top of headlines of the NWSL weekend, and a very special moment of the week featuring some inaugural silverware in the Concacaf W Champions Cup._______________Articles mentioned on the show: Stina Blackstenius is a subtle striker who helped Arsenal win another Champions League titleChloe Kelly says she ‘found happiness at Arsenal after being in a dark place'Barcelona seemed destined for a third straight Champions League triumph. What went wrong?How Arsenal became European champions for a second time: Pressing, doubling up and smart subsHow Champions League winners Arsenal benefited from top coaching and a tight league tableArsenal pull off the upset, beating Barcelona to capture second Women's Champions League title_______________HOST: Jillian SakovitsGUEST: Art de Roche, Laia CervelloPRODUCER: Theo Lloyd-HughesVIDEO PRODUCER: Lia GriffinEXECUTIVE PRODUCER: Emily Olsen_______________Get in touch: ⁠⁠fulltime@theathletic.com⁠⁠Follow on Instagram and TikTok: @tafulltimeSubscribe to the Full Time newsletter ⁠⁠here⁠⁠Visit the Yahoo Women's Sports hub ⁠⁠here Hosted on Acast. See acast.com/privacy for more information.

Nate sits down with Corbin Curley and Bill Roche from the Cullman Summer Series Committee. They are helping to organize the first ever Cullman Derby Days event, which is a Soapbox Derby race in Unadilla this July. They explain how they got this idea and the impact it could have locally. Listen in to learn more about how you can get involved or sign up to race. 

The turbulence that has come with the Trump administration's policies related to the U.S. biopharmaceutical industry is creating an opening for Europe to bolster its life sciences industry. On the latest BioCentury This Week podcast, BioCentury's editors look at how Europe can capitalize on staffing cuts at FDA and NIH and an uncertain policy environment to lure back talent to bolster regulatory agencies and biotech R&D engines and attract assets and partners from China.The editors also discuss two biotech deals driven by former leaders of BD at Roche, Biomarin's James Sabry and Sophie Kornowski at Boston Pharmaceuticals. Under the leadership of Sabry and CEO Alexander Hardy, Biomarin delivered its first takeout in a decade by acquiring Inozyme as it positions itself to take advantage of a regulatory and policy environment that they believe is favorable to their rare disease strategy. CEO Kornowski, meanwhile, executed on a plan to focus her company on a single liver disease asset that GSK acquired for $1.2 billion up front. Finally, BioCentury's editors discuss the management shake-up at obesity company Novo Nordisk, where Lars Fruergaard Jørgensen, the leader who spearheaded Novo Nordisk's transformation into a dominant player in obesity, is stepping down.Chan Zuckerberg Chicago Biohub is hosting an exclusive, invite-only reception on June 3 — the eve of BioCentury's Grand Rounds conference — gathering top voices in biotech innovation and investment to exchange bold ideas, spark new collaborations and channel the energy of Chicago's thriving innovation ecosystem. If you're interested in attending, please register here. This episode was sponsored by Jeito Capital.View full story: https://www.biocentury.com/article/655964#biotech #biopharma #pharma #lifescience #politics #policy #law00:01 - Sponsor Message: Jeito Capital05:05 - European Biotech's Moment?19:00 - Boston Pharma, Biomarin Deals29:41 - Novo Nordisk CEOTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

While few doubt the opportunity represented by real-world evidence, some concerns remain about its validity compared to traditional forms of clinical evidence, particularly among regulators. To address these concerns, IQVIA Consumer Health's vice president of global research and development and real-world evidence services, Volker Spitzer, suggests that incorporating some elements of traditional trials, such as randomization, is a good way to persuade regulators that RWE can be used for consumer health innovation, for example in generating new claims or supporting Rx-to-OTC switch. Looking forward, Spitzer is excited about the ways in which digital health tools and artificial intelligence can be used to expand the scope of RWE as well as drive personalization for consumers. Timestamps: 3:00 - Addressing concerns about RWE's scientific rigour and validity 12:00 – Regulators' views of RWE, particularly for consumer health 16:00 – Use of RWE for Rx-to-OTC switch 22:00 – The future of RWE Guest Bio: Volker Spitzer has more than 30 years of R&D experience spanning the consumer health sector, ingredients industry, and academia. Beginning his career as a professor in pharmaceutical sciences, he ascended to global positions encompassing R&D, innovation, licensing/M&A, and medical marketing at firms like Roche, DSM Nutritional Products, and Bayer. Since October 2017, Spitzer has been affiliated with IQVIA Consumer Health, serving as the vice president for global R&D and RWE Services. His purview primarily includes clinical research, RWE, virtual trials, and the burgeoning field of digital health. He has penned over 80 scientific publications, whitepapers and textbooks centered on science and innovation.

We are happy to have Kayra Otaner as a special guest on the Absolute AppSec podcast. Kayra (kayraotaner on LinkedIn and X/twitter), the current Director of DevSecOps at Roche, brings over 15 years of cybersecurity leadership experience from New York and Wall Street. He's led DevSecOps and DevOps teams across a variety of organizations, including ADP, Voice, and adMarketplace, and has served as a trusted CTO advisor for Trendyol. His background also includes cybersecurity consulting for the Turkish Navy, where he helped develop a defense solution that was later deployed in NATO's Locked Shields cyber defense war games in Tallinn. Kayra is a frequent speaker at international DevSecOps conferences and serves on the Business and Computer Science Advisory Board at Middlesex County College in New Jersey. During this episode of the podcast Kayra discusses his journey into information security and spurs on his recent thoughts on authenticating open source developers through models similar to TSA PreCheck.

Fener Rum Patriği Bartholomeos, Vatikan'da görüştüğü yeni Papa 14. Leo'yu resmen Türkiye'ye davet etti. İngiltere ve AB, Brexit sonrası ikili ilişkileri yeniden şekillendirecek kapsamlı bir işbirliği anlaşmasına vardı. Bu bölüm Roche Türkiye hakkında reklam içermektedir. Roche Türkiye, 20 Mayıs Dünya Klinik Araştırmalar Gününü kutluyor. Klinik araştırmaların sağlık alanındaki dönüştürücü etkisine dikkat çekmeyi hedefleyen Roche İlaç Türkiye, 65 yılı aşkın süredir bilimin gücünden aldığı ilhamla klinik çalışmalar alanında faaliyetler yürütüyor. Ayrıntılı bilgiye buradan ulaşabilirsiniz. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ecoutez les infos de la Loire avec le flash info de 07h00 de ce mardi 20 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 19h00 de ce mardi 20 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 18h00 de ce mardi 20 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 16h00 de ce mardi 20 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 12h00 de ce mardi 20 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 08h00 de ce mardi 20 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 16h00 de ce lundi 19 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 19h00 de ce lundi 19 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 18h00 de ce lundi 19 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 12h00 de ce lundi 19 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 08h00 de ce lundi 19 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 07h00 de ce lundi 19 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

On this week's Inside Indiana Business with Gerry Dick, we continue our “Business at the Brickyard” series from the newly renovated Indianapolis Motor Speedway Museum. The $60 million overhaul is already drawing crowds and boosting memberships, with new interactive exhibits, STEM learning opportunities and a major spotlight on Roger Penske's legacy. Penske Entertainment's Allison Melangton joins Gerry to discuss how IndyCar is strengthening its connection to fans across Indiana — from porch parties and statewide fan fests to collaborations with the arts community. Also in this episode: Big sales at the State Fairgrounds: Mecum Auctions wraps up nine days of bidding with more than 3,000 collector cars and over $100 million in transactions. Roche ramps up in Indy: The company will invest $550 million in its diagnostics campus and bring hundreds of jobs to the city. Slate Auto chooses Warsaw: The electric vehicle startup is repurposing a former printing facility to build affordable EVs, with production starting in 2026. “100 Days to Indy” returns: The hit docuseries gives viewers a behind-the-scenes look at IndyCar stars and their lives off the track. Sam Schmidt marks 25 years: The racing legend expands his impact through the Driven NeuroRecovery Center in Carmel, offering new hope to people with spinal cord injuries. Higher ed investments: Goshen College opens a $21 million nursing training center, and Eli Lilly teams up with Purdue for a $250 million research collaboration. Trackside eats: Yelp's Brittany Smith shares five fan-favorite restaurants near Indiana racetracks, including stops in Speedway, Kokomo and Hobart. As the Indy 500 approaches, we spotlight the people, companies and communities fueling Indiana's motorsports economy.

Ecoutez les infos de la Loire avec le flash info de 17h00 de ce dimanche 18 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ecoutez les infos de la Loire avec le flash info de 09h00 de ce dimanche 18 mai 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

A recent operation in the Middle East may have uncovered the remains of a slain humanitarian worker from Indianapolis. The Swiss biotech company Roche announced plans for a $550 million expansion of its Indianapolis diagnostics and manufacturing hub. The Indianapolis Housing Agency presented its new 12-month plan. Activists and northwest Indiana residents are asking the state to reduce water pollution coming from BP's Whiting Refinery. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Drew Daudelin, Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

This Oncology PER®Spectives™ podcast explores the role of EZH2 in metastatic castration-resistant prostate cancer (mCRPC) progression and its synergy with androgen receptor inhibitors. In this podcast, experts Neeraj Agarwal, MD, FASCO; Himisha Beltran, MD; and Maha Hussain, MD, FACP, FASCO, discuss the management of mCRPC. Acknowledgment of Educational Grant Support This activity is supported by an educational grant from Pfizer Inc. Accreditation/Credit Designation Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours. Instructions on How to Receive Credit Listen to this podcast in its entirety. Go to gotoper.com/credit and enter code: 6947 Answer the evaluation questions. Request credit using the drop-down menu. You may immediately download your certificate. Today's faculty are: Neeraj Agarwal, MD, FASCO Professor of Medicine Senior Director for Clinical Research HCI Presidential Endowed Chair of Cancer Research Director, Center of Investigational Therapeutics Director, Genitourinary Oncology Program Huntsman Cancer Institute, University of Utah (NCI-CCC) Salt Lake City, UT Disclosures: Grant/Research Support (paid to institution): Arvinas, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Calithera, Celldex, Clovis, Crispr, Eisai, Eli Lilly, EMD Serono, Exelixis, Genentech, Gilead, GlaxoSmithKline, Immunomedics, Janssen, Lava, Merck, Nektar, Neoleukin, Novartis, Oric, Pfizer, Roche, Sanofi, Seagen, Takeda, Tra-con Himisha Beltran, MD Associate Professor of Medicine Director of Translational Research Within Medical Oncology Harvard Medical School Lank Center for Genitourinary Oncology and the Division of Molecular and Cellular Oncology Dana Farber Cancer Institute Boston, MA Disclosures: Grant/Research Support: Circle Pharma, Daiichi Sankyo, Novartis; Adviser: Amgen, AstraZeneca, Daiichi Sankyo, Novartis Maha Hussain, MD, FACP, FASCO Genevieve E. Teuton Professor of Medicine Professor, Medicine (Hematology/Oncology) Deputy Director Robert H. Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine Chicago, IL Disclosures: Advisory Board: AstraZeneca, Bayer, Convergent Therapeutics, Honoraria: AstraZeneca, Bayer The staff of Physicians' Education Resource®, LLC, have no relevant financial relationships with ineligible companies. PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process. Off-Label Disclosure and Disclaimer This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient's medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity. Release Date May 14, 2025 Expiration Date May 14, 2026

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Bayer has announced a restructuring that will result in 2,000 job cuts and a reduction in management layers. CEO Bill Anderson believes Trump's most favored nations policy could provide an opportunity for European countries to contribute more to biopharma innovation. Galapagos has abandoned plans for a spinout and cell therapy, causing a stir in the industry. Trump's most favored nation policy has led to a sell-off of PBMs, but analysts believe it may not have a significant impact without further congressional action. Sino Biological offers solutions for autoimmune diseases, with reagents for nearly 50 different conditions. In other news, CMS is preparing for a new cycle of drug negotiations, Azafaros has raised $150 million for rare neuro-metabolic diseases, and Roche's Genentech is investing $700 million in a North Carolina plant. 10x Genomics has cut 8% of its workforce, and there are upcoming webinars on biotech downturns and AI in life science R&D. Job opportunities include positions at 4D Molecular Therapeutics, Takeda, and Regeneron Pharmaceuticals.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The White House has announced a new drug pricing policy that includes the revival of the most favored nations rule and extends to the private markets, leveraging the patent system, drug importation, and more. Meanwhile, Lilly's Zepbound has been found to have a superior benefit-risk ratio compared to Novo's Wegovy, BMS and Sanofi settle a Plavix lawsuit with Hawaii for $700 million, and biopharma companies are focusing on developing a cure for HIV as federal funding for related research is being cut. Sino Biological offers comprehensive solutions for autoimmune diseases, and Roche promises a $300 million investment in China production after a multibillion-dollar investment in the US. On the other hand, Lexeo and IGM have both announced significant layoffs. Novartis CEO has expressed concerns about Trump's pricing controls.Funding for HIV-related research and infrastructure is being cut by the Trump administration, leading biopharma companies like Gilead and Immunocore to focus on finding a cure for HIV. In the field of neurology, there is a need for more precise diagnostic tools to effectively treat neurodegenerative conditions. The new HHS vaccine requirement has been criticized by leading vaccine physician Paul Offit as potentially being anti-vaccine activism disguised as policy. Companies like Novartis, Bayer, and AstraZeneca are exploring new indications and innovations in radiopharmaceuticals, hoping to capitalize on a market that could reach $16 billion by 2033. The FDA has faced delays in reviewing certain drugs, while biotech stocks have fallen after the appointment of Vinay Prasad to succeed Marks at CBER. Vertex has decided to abandon AAV in the gene therapy space.Upcoming events include a webinar on surviving and thriving in the biotech downturn. Job opportunities in the biopharma industry include positions at Takeda, Daiichi Sankyo, and AbbVie. Heather McKenzie, senior editor at BioSpace, is open to suggestions for future coverage topics in neuroscience, oncology, cell & gene therapy, metabolic, or other areas.

Donald Trump erwägt, auch auf Medikamente Zölle zu erheben. Dies würde die Schweiz hart treffen, die Pharmabranche ist ein bedeutender Sektor der Wirtschaft. Wie will der Branchenverband Interpharma die USA davon abhalten? Der Chef von Interpharma ist zu Gast im Tagesgespräch. Die USA sind ein wichtiger Absatzmarkt für Schweizer Pharma-Firmen. Präsident Trump sieht die Versorgungssicherheit der USA in Gefahr, weil viele Medikamente importiert werden. Er droht darum, auch auf Medikamente Zölle zu erheben, damit die Produktion im Inland angekurbelt wird. Was würde das für die Schweiz bedeuten? Wie wollen sich die Schweizer Pharma-Firmen dagegen wehren? Und was heisst es für die Schweiz, wenn Novartis und Roche ihre Investitionen in die USA weiter ausbauen? Der Geschäftsführer von Interpharma, René Buholzer, spricht zum ersten Mal über die Position von Interpharma in dieser Frage, er ist zu Gast im Tagesgespräch.

The potential for real world evidence (RWE) is huge, according to enthusiasts, but to the uninitiated it can seem like a complicated and forbidding subject. In this Over the Counter double episode, IQVIA Consumer Health's vice president of global research and development and real-world evidence services, Volker Spitzer, makes understanding real world evidence easy. We start with the basics, with what it is and what companies need to know about it, and what the key difference is with randomised control trials. Many companies are already using real world evidence, Volker notes, and he extracts some key lessons for companies interested in trying it out based on his extensive experience working with industry on such projects. Timestamps 2:00 – Introductions 4:00 – What is real world evidence? 5:00 – Can RWE and clinical trials complement each other? 10:00 – Why RWE is particularly attractive today 14:00 – Don't reinvent the wheel 18:00 – Why is this important for consumer health companies? 25:00 – Why RWE is often a good value option, especially for SMEs 33:00 – Applications of RWE in consumer health Guest Bio Volker Spitzer has more than 30 years of R&D experience spanning the consumer health sector, ingredients industry, and academia. Beginning his career as a professor in pharmaceutical sciences, he ascended to global positions encompassing R&D, innovation, licensing/M&A, and medical marketing at firms like Roche, DSM Nutritional Products, and Bayer. Since October 2017, Volker has been affiliated with IQVIA Consumer Health, serving as the vice president for global R&D and RWE Services. His purview primarily includes clinical research, RWE, virtual trials, and the burgeoning field of digital health. He has penned over 80 scientific publications, whitepapers and textbooks centered on science and innovation.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Two companies, Beam Therapeutics and Verve Therapeutics, have developed lead candidates using a safer alternative to conventional CRISPR called base editing. Clinical results have been promising. FDA insiders are calling on FDA Commissioner Marty Makary to fight against agency politicization. The Trump administration, including HHS Secretary Robert F. Kennedy Jr., is accused of distorting and denying scientific truths and potentially censoring information.FDA action alerts include expansion bids for drugs by GSK and Merck. A new AI-powered solution called Generative AIPTP helps life sciences firms streamline clinical workflows. The FDA is rehiring travel staff as lapses begin to show.RFK Jr. is driving a wedge into vaccine conversations. WHO may add obesity drugs for adults to the essential medicines list. Various companies like Merck, GSK, and Roche present key data at AACR 2025.HHS will require placebo-controlled trials for all new vaccines in a radical departure from past practices. Tariffs dominate Q1 earnings, AACR excites the cancer space, CEO pay gaps are discussed, and more news and events are highlighted.

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Daniel Eckert über zwei Gipfelstürmer im Dax, das 20.000-Punkte-Comeback des Nasdaq und was diese Woche sonst noch wichtig wird. Außerdem geht es um Rheinmetall, Siemens, Siemens Energy, Münchener Rück, RWE, BASF, Aixtron, Berkshire Hathaway, Novo Nordisk, Eli Lilly, Pfizer, Merck KGaA, Viking Therapeutics, Gilead, Regulus Therapeutics, SpringWorks Therapeutics, Nuvalent, Legend Biotech, Dexcom, Arcellx, Blueprint Medicines, Roche und Johnson&Johnson. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

With Brian Roche, James Meager and Tanya Unkovich

durée : 00:30:53 - Les Nuits de France Culture - par : Philippe Garbit, Albane Penaranda, Mathilde Wagman - En 1955, dans l'émission Le Monde comme il va, Jacques Capdeville proposait un voyage dans le Bas-Rhin, invitant l'auditeur à découvrir la Vallée de la Bruche, le massif du Donon, le lac de la Maix et le Ban de la Roche, à travers l'histoire, les anecdotes et les légendes qui ont marqué ces lieux. - réalisation : Virginie Mourthé

Die Ankündigungen von Roche und Novartis, Milliarden in den USA zu investieren, sorgten jüngst für Aufsehen und lösten hierzulande Sorgen über eine Standortschwächung aus. Sind die Summen womöglich als Abwendung von Europa zu verstehen? Weitere Themen: In der Schweiz erfreut sich das Homeoffice auch nach den Pademiejahren noch grosser Beliebtheit. Das zeigt der Blick auf Stellenportale im Internet: Die Zahl der Stellen, die zumindest teilweise Arbeit im Homeoffice anbieten, nimmt weiter zu. Im April 1955 wurde in den USA die Impfung gegen Kinderlähmung zugelassen. Seither hat die Krankheit zwar ihren Schrecken verloren, aber es gibt sie noch. Jüngst gab es in New York einen Erkrankungsfall und in Afghanistan und Pakistan ist Polio endemisch. Droht auch hierzulande eine Rückkehr der Krankheit?

Die Schweiz ist zurück in Deutschland - an der Börse! Schweizer Aktien können endlich wieder problemlos gehandelt werden.

Interview starts at 25:00 William W. Warwick IV joins us for a chat about the moons of Mars, Phobos and Deimos and his new book "The Phobos Enigma - Evidence of Artificial Nuclear Pulse Detonation On Phobos". We also talk about the monolith on Phobos, some theories about how they may have formed, orbital paths, cataclysms, the Roche limits, Kaidun meteor, Hopi prophecy and the elders, Mars seasons, corruption, stable coin and technology. https://www.facebook.com/wikileaksufos/ Become a Lord or Lady with 1k donations over time. And a Noble with any donation. Leave Serfdom behind and help Grimerica stick to 0 ads and sponsors and fully listener supported. Thanks for listening!! Help support the show, because we can't do it without ya. Support the show directly: https://grimericacbd.com/ CBD / THC Gummies and Tinctures http://www.grimerica.ca/support https://www.patreon.com/grimerica http://www.grimericaoutlawed.ca/support www.Rokfin.com/Grimerica https://www.eventbrite.com/e/experience-the-ultimate-hunting-adventure-in-alberta-canada-tickets-1077654175649?aff=ebdsshcopyurl&utm-campaign=social&utm-content=attendeeshare&utm-medium=discovery&utm-term=organizer-profile&utm-share-source=organizer-profile The Eh- List site. Canadian Propaganda Deconstruction https://eh-list.ca/ The Eh-List YouTube Channel: https://youtube.com/@theeh-list?si=d_ThkEYAK6UG_hGX Adultbrain Audiobook YouTube Channel: https://www.youtube.com/@adultbrainaudiobookpublishing https://grimericaoutlawed.ca/The newer controversial Grimerica Outlawed Grimerica Show Check out our next trip/conference/meetup - Contact at the Cabin www.contactatthecabin.com Our audio book website: www.adultbrain.ca www.grimerica.ca/shrooms and Micro Dosing Darren's book www.acanadianshame.ca Grimerica on Rumble: https://rumble.com/c/c-2312992 Join the chat / hangout with a bunch of fellow Grimericans Https://t.me.grimerica https://www.guilded.gg/i/EvxJ44rk Leave a review on iTunes and/or Stitcher: https://itunes.apple.com/ca/podcast/grimerica-outlawed http://www.stitcher.com/podcast/grimerica-outlawed Sign up for our newsletter https://grimerica.substack.com/ SPAM Graham = and send him your synchronicities, feedback, strange experiences and psychedelic trip reports!! graham@grimerica.com InstaGRAM https://www.instagram.com/the_grimerica_show_podcast/ Tweet Darren https://twitter.com/Grimerica Can't. Darren is still deleted. Purchase swag, with partial proceeds donated to the show: www.grimerica.ca/swag Send us a postcard or letter http://www.grimerica.ca/contact/ Episode ART - Napolean Duheme's site http://www.lostbreadcomic.com/ MUSIC https://brokeforfree.bandcamp.com/ - Something Wobbly Felix's Site sirfelix.bandcamp.com - Should I

The three Big Pharma companies on their earnings calls this week tried to reassure investors that they have the global footprints to mitigate the effects of tariffs.

After 23 years of service, one can liken Jog into Spring to Opening Day here in Independence!It's an event born of heart + soul as a gift. A gift in memory of a local mother + teacher in support of local students - some of whom practice here at Studio 108. AND, you get to RUN!! Ashley and Breanna  Roche sit with me today to tell the story of their mother and their family's non-profit organization that has organized this event - rain or shine - and mostly rain - for the past many years. The weather this year looks iffy but the love at this event is a sure thing! PS All who sign up to run with the studio receive a studio tank top. Please sign up for both the run AND the studio event via these two links: https://runsignup.com/Race/OH/Independence/JogIntoSpringwww.studio108.net/community-events

Roche and Regeneron, two of the world's largest pharmaceutical companies, have announced a combined $56 billion investment that's set to transform U.S. real estate and manufacturing. Billions of dollars will go into expanding research and manufacturing facilities across key states like California, Indiana, New York, and North Carolina, creating thousands of new jobs. These investments signal long-term confidence in the U.S. market and could spark a boom in life sciences real estate. As the pharmaceutical industry navigates potential new tariffs, this expansion is reshaping global supply chains and strengthening biotech hubs in the U.S. Learn how these developments could impact investors and the future of American manufacturing. Topics Discussed: 00:00 Big Pharma Announcements 00:22 Roche's US Plan 01:01 Regeneron's US Plan 01:55 President Trump's Tariffs  02:15 Other Expansions 02:33 Real Estate Investors LINKS Download Your Free Top 5 Cities to Invest in 2025 PDF!https://www.realwealth.com/1500 JOIN RealWealth® FOR FREE https://realwealth.com/join-step-1 FOLLOW OUR PODCASTS Real Wealth Show: Real Estate Investing Podcast https://link.chtbl.com/RWS Real Estate News: Real Estate Investing Podcast: https://link.chtbl.com/REN    

Driver plows his car into Vancouver crowd. Gerry Dick talks Roche investment in Indiana and great happenings with the Pacers and the Fever. Karoline Leavitt has early White House briefing regarding immigration policy. Tom Homan lays into BidenSee omnystudio.com/listener for privacy information.

Arresting this Wisconsin judge was the absolutely right thing to do. Trump and Zelensky meet at the Vatican. Let WFYI compete just like WIBC. Tony’s surgery and recovery. JMV joins to talk about the Pacers, and the Colts’ draft pick. Popcorn Moment: Democrats are now admitting that they didn't cover the Biden story correctly. Marketplace: Freedom Dagger. Micah Beckwith controversial 3/5 comments. Driver plows his car into Vancouver crowd. Gerry Dick talks Roche investment in Indiana and great happenings with the Pacers and the Fever. Karoline Leavitt has early White House briefing regarding immigration policy. Tom Homan lays into BidenSee omnystudio.com/listener for privacy information.

Donate (no account necessary) | Subscribe (account required) Join Bryan Dean Wright, former CIA Operations Officer, for the Friday Roundup on The Wright Report—covering the week's biggest stories and your top listener questions. Another Deportation Reversal Ordered by a Judge – A Venezuelan teen deported under Trump's Alien Enemies Act must now be returned to the U.S. after a judge ruled the Biden-era protections for minors take legal precedence. Trump's Five-Bucket Economic Strategy: Momentum and Warnings – Big reshoring wins with Roche investing $50B in U.S. drug manufacturing and Hyundai moving SUV production from Mexico to Alabama. Meanwhile, Walmart says it can hold prices, but warns of potential shortages. Tariff Talks and Global Trade Realignment – 15 nations are in advanced talks with Trump's team to reduce tariffs, including Vietnam and South Africa. U.S. tariff revenue is surging, but American importers remain unsure how much of the cost will be passed on to consumers. Young Americans Choose Trades Over College – Gen Z is abandoning overpriced universities for skilled trades, boosting Trump's efforts to revive the working class and address student debt. Listener Questions: How U.S. Intelligence Really Assesses Threats – Bryan walks listeners through how intel assessments are made—and how partisan leaks and foreign influence can distort the truth, especially on hot-button topics like Iran and Venezuela. Should We Go to War with Iran? – Bryan lays out the moral and strategic stakes of conflict, emphasizing the burden of leadership and the need for unshakable justification before risking American lives. The Republic Is Dead? What's Next? – Thoughtful responses to Bryan's commentary on America's decline include whether the nation can be saved by law and order, and how local resilience might help restore national strength. Get the facts, the analysis, and the truth—only on The Wright Report. "And you shall know the truth, and the truth shall make you free." - John 8:32​  

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über Pech für Intel, eine Übernahme bei Merck und die Jagd auf High Beta. Außerdem geht es um BYD, Pfizer, Merck, SpringWorks Therapeutics, Nestlé, Roche, Novartis, Richemont, Zürich, Straumann, Geberit, CI Com SA, BB Biotech, Cosmo Pharmaceuticals, LEM Holding, Cicor Technologies, Medmix, BioVersys, Stadler Rail AG, Bystronic, Allreal Holding und Cembra Money Bank, Bitcoin, Meyer Burger, Kudelski, Molecular Partners, BB Biotech, LEM Holding, COSMO Pharmaceuticals und Rieter Holding. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Good evening: The show begins in Switzerland where a decision is made to build Roche and Novartis plants in the US... 1927 SWITZERLAND This appears to be an email from John Batchelor detailing the schedule for a CBS Eye on the World radio/podcast show. Here's a brief summary of the program segments: First Hour: 9:00-9:15: Markets - Switzerland Pharma and US Manufacturing (Liz Peek) 9:15-9:30: Markets - Biden in Disorder (Liz Peek) 9:30-9:45: Lebanon - Hezbollah Weapons (David Daoud, Bill Roggio) 9:45-10:00: Iran - Discussed as "Defeated in All Directions" (David Daoud, Bill Roggio) Second Hour: 10:00-10:15: Trade and Congress history (Philip Wallach, AEI/Civitas Institute) 10:15-10:30: Continued Trade and Congress discussion 10:30-10:45: Russia and Oil Prices (Ekaterina Zolotova) 10:45-11:00: China and Deepseek Deceptions (Jack Burnham) Third Hour: 11:00-11:15: London Calling - Blaming Japan, Germany, China (Joseph Sternberg) 11:15-11:30: London Calling - Rachel Reeves in Washington 11:30-11:45: Antisemitism at Harvard (Peter Berkowitz) 11:45-12:00: Progressivism at Harvard (Peter Berkowitz) Fourth Hour: 12:00-12:15: Iran Nuclear Weapons (John Bolton) 12:15-12:30: USAF Kinetic Warfare in CENTCOM (General Blaine Holt) 12:30-12:45 & 12:45-1:00: Soviet Kompromat and Trump in the 1980s (Craig Unger) Would you like me to elaborate on any of these segments or topics?

Episode 567: Neal and Toby chat about Tesla reporting a wide miss on its Q1 earnings (no surprise there), but Elon Musk says he is coming back from Washington to Tesla. Then, RFK Jr.'s move to ban food dyes in the food supply could shake up the industry. Also, Chobani and Roche are now the latest companies that have announced investments of new factories on US soil amid tariff threats. Meanwhile, Japan faces a rice shortage crisis that forces it to import rice from neighboring countries.  Subscribe to Morning Brew Daily for more of the news you need to start your day. Share the show with a friend, and leave us a review on your favorite podcast app. Visit https://planetoat.com/ to learn more! Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow Learn more about your ad choices. Visit megaphone.fm/adchoices

Missoula Big Sky baseball coach Ryan Roche joins the show to discuss the ups and downs of the Eagles' inaugural season. Plus: former Montana tackle Brandon Casey discusses his Draft prep as he hopes to get a shot at the NFL, and Colter Nuanez highlights this week's top performers on the Treasure State Stars.

Plus, The U.S. and India agree to broad terms of negotiation for a potential bilateral trade deal. And pharma giant Roche pledges to invest $50 billion in the U.S. Luke Vargas hosts. Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Arsenal dominated Real Madrid to deservedly win 2-1 at the Bernabeu, dumping the holders out of the Champions League and marching on to the semi-finals. Hear what it was like in Madrid from Amy Lawrence and James McNicholas, as Art de Roche and Ian Stone reflect on a monumental night for Arsenal - we even managed to get Adrian Clarke away from the snooker to send over his thoughts too. We talk about the team's immense performances, the incredible job Mikel Arteta has done in building this team and back to back MOTM performances from Declan Rice. Plus, reflections on Bukayo Saka's iconic Bernabeu goal, another outstanding performance from Myles Lewis-Skelly, Jakub Kiwior's stellar defending and our make-shift No.9 Mikel Merino with two fantastic assists. Oh, and yes, we look ahead to Ipswich at the weekend. Warning: strong language and scenes of jubilation throughout this show Producer: Robby Williams Learn more about your ad choices. Visit megaphone.fm/adchoices

Arsenal dominated Real Madrid to deservedly win 2-1 at the Bernabeu, dumping the holders out of the Champions League and marching on to the semi-finals.Hear what it was like in Madrid from Amy Lawrence and James McNicholas, as Art de Roche and Ian Stone reflect on a monumental night for Arsenal - we even managed to get Adrian Clarke away from the snooker to send over his thoughts too.We talk about the team's immense performances, the incredible job Mikel Arteta has done in building this team and back to back MOTM performances from Declan Rice.Plus, reflections on Bukayo Saka's iconic Bernabeu goal, another outstanding performance from Myles Lewis-Skelly, Jakub Kiwior's stellar defending and our make-shift No.9 Mikel Merino with two fantastic assists.Oh, and yes, we look ahead to Ipswich at the weekend.Warning: strong language and scenes of jubilation throughout this showProducer: Robby Williams Hosted on Acast. See acast.com/privacy for more information.

Arsenal are through to the semi-finals of the Champions League for only the third time in their history - and they had to beat the holders to do it.So how far does that 5-1 win on aggregate propel Mikel Arteta's project forward? And crucially, can they now go all the way in the Champions League?Host: Ayo AkinwolereWith: Art de Roche, Guillermo Rai, Charlie EccleshareExecutive Producer: Adey MoorheadProducer: Mike Stavrou & John Rogers Hosted on Acast. See acast.com/privacy for more information.

Arsenal are through to the semi-finals of the Champions League for only the third time in their history - and they had to beat the holders to do it. So how far does that 5-1 win on aggregate propel Mikel Arteta's project forward?  And crucially, can they now go all the way in the Champions League? Host: Ayo Akinwolere With: Art de Roche, Guillermo Rai, Charlie Eccleshare Executive Producer: Adey Moorhead Producer: Mike Stavrou & John Rogers Learn more about your ad choices. Visit megaphone.fm/adchoices